NCT03917238Active, not recruiting
Beta Cell Imaging During and Shortly After the Honeymoon Phase of T1D
Comparison of the Beta Cell Mass During and Shortly After the Honeymoon Phase of Type 1 Diabetes Using Gallium-68-exendin PET
Source: ClinicalTrials.gov · Last updated 5 Jan 2024
Brief summary (registry, in English)
The primary goal is to correlate beta cell mass to beta cell function from measurements during and shortly after the honeymoon phase of type 1 diabetes, to improve understanding of the change in metabolic control after the honeymoon phase.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 14 (estimated)
- First submitted
- 13 Mar 2019
- Start date
- 11 Oct 2019
- Primary completion date
- 25 Nov 2026
- Lead sponsor
- Radboud University Medical Center
- Diseases
- Type 1 diabetes
- NCT number
- NCT03917238
What you commit to
- Study type: Interventional
- Planned participants: 14
- From 11 Oct 2019 to the primary completion date, 25 Nov 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous treatment (within 6 months) with synthetic Exendin (Exenatide, Byetta®) or Dipeptidyl-Peptidase IV inhibitors
Other illness
- Liver disease
- Renal disease
Age
- Age \<16 years
Other
- Pregnancy or the wish to become pregnant within 6 months after the study
- Breastfeeding
- BMI \<17 kg/m2 or BMI \>30 kg/m2
- When the end of the honeymoon phase is not observed within 11 to 13 months after the inclusion of the subject
- Inability to sign informed consent
Who the study is looking for
- Age ≥ 16 years
- Diagnosed with T1D
- Presence of anti-GAD
- Subject is in honeymoon phase
- 17 ≤ BMI ≥ 30 kg/m\^2 at moment of visit
- Ability to sign informed consent
Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Radboud University Medical Center Coordinator of this site? Confirm its status | Nijmegen | Netherlands | Unknown status |
| Diabeter Coordinator of this site? Confirm its status | Rotterdam | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.